Mutations in other cancer-related genes, such as SMAD4, PI3KCA, PTEN, and BRAF, have been reported by previous studies in both IPMNs and pancreatic cancers with lower prevalence (30–33). This evidence concerns the gene BRAF and pancreatic neoplasm.